Algernon Pharmaceuticals Inc. (AGN.CN)

CAD 0.07

(0.0%)

Revenue Summary of Algernon Pharmaceuticals Inc.

  • Algernon Pharmaceuticals Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Algernon Pharmaceuticals Inc.'s latest quarterly revenue in 2024 Q2 was - CAD , down 0.0% from previous quarter.
  • Algernon Pharmaceuticals Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • Algernon Pharmaceuticals Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Algernon Pharmaceuticals Inc. reported a quarterly revenue of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Algernon Pharmaceuticals Inc. reported a quarterly revenue of - CAD for 2024 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Algernon Pharmaceuticals Inc. (2023 - 2015)

Historical Annual Revenue of Algernon Pharmaceuticals Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%

Peer Revenue Comparison of Algernon Pharmaceuticals Inc.

Name Revenue Revenue Difference
Asep Medical Holdings Inc 21.14 Thousand CAD 100.0%
BetterLife Pharma Inc. - CAD NaN%
BioVaxys Technology Corp. - CAD NaN%
ChitogenX Inc. - CAD NaN%
Rapid Dose Therapeutics Corp. 1.02 Million CAD 100.0%
Defence Therapeutics Inc. - CAD NaN%
Entheon Biomedical Corp. 250.32 Thousand CAD 100.0%
Gemina Laboratories Ltd. - CAD NaN%
Glow Lifetech Corp. 43.93 Thousand CAD 100.0%
Lexston Life Sciences Corp. - CAD NaN%
Pharmala Biotech Holdings Inc. 532 Thousand CAD 100.0%
Doseology Sciences Inc. 98.52 Thousand CAD 100.0%
MYND Life Sciences Inc. - CAD NaN%
Nova Mentis Life Science Corp. 28.34 Thousand CAD 100.0%
PharmaTher Holdings Ltd. - CAD NaN%
PreveCeutical Medical Inc. - CAD NaN%
Telescope Innovations Corp. 595.39 Thousand CAD 100.0%